4//SEC Filing
CHAI CHRISTOPHER Y 4
Accession 0001209191-20-047832
CIK 0001510487other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:01 PM ET
Size
10.0 KB
Accession
0001209191-20-047832
Insider Transaction Report
Form 4
CHAI CHRISTOPHER Y
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-08-18$99.37/sh−7,500$745,240→ 3,539 total - Exercise/Conversion
Common Stock
2020-08-18$3.00/sh+7,500$22,483→ 11,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-08-18−7,500→ 56,982 totalExercise: $3.00Exp: 2023-12-11→ Common Stock (7,500 underlying)
Holdings
- 3,302(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $99.28 to $99.50 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Shares indirectly held by Christopher Chai, as custodian for his children under California Uniform Transfer to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
- [F4]The stock option is fully vested and immediately exercisable.
Documents
Issuer
Principia Biopharma Inc.
CIK 0001510487
Entity typeother
Related Parties
1- filerCIK 0001413823
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 8:01 PM ET
- Size
- 10.0 KB